Filter
3424
Text search:
National
Medicines
Policy
Featured
Recommendations
329
New Publications
975
Language
Document type
No document type
1792
Studies & Reports
645
Guidelines
471
Manuals
195
Strategic & Response Plan
181
Fact sheets
48
Training Material
45
Situation Updates
26
Brochures
6
Resource Platforms
6
Infographics
5
Online Courses
4
Countries / Regions
Global
169
India
132
Kenya
122
Uganda
93
South Africa
91
Ethiopia
83
Nigeria
71
Nepal
69
Western and Central Europe
68
Sierra Leone
67
Ghana
63
Liberia
62
Malawi
61
Africa
61
Myanmar / Burma
59
Zambia
55
Tanzania
54
Bangladesh
50
Latin America and the Carribbean
50
Ukraine
49
Namibia
46
Rwanda
40
Eastern Europe
33
Zimbabwe
29
South–East Asia Region
27
Asia
27
Philippines
23
Indonesia
21
Lesotho
21
Congo, Democratic Republic of
20
Syria
20
Cambodia
20
Mozambique
17
Botswana
15
East and Southern Africa
15
Guinea
14
Haiti
14
Senegal
13
Pakistan
13
West and Central Africa
13
Burkina Faso
12
Eswatini/ Swaziland
12
Yemen
12
Middle East and North Africa
12
Venezuela
11
Russia
11
Cameroon
10
South Sudan
10
Eastern Europe and Central Asia
10
Thailand
9
Sudan
9
Afghanistan
8
Brazil
8
Moldova
8
Somalia
7
Benin
7
Madagascar
7
Western Pacific Region
7
North America
7
Lebanon
6
Peru
6
Vietnam
6
Jordan
5
China
5
North Macedonia
5
Paraguay
5
Poland
5
Albania
5
Laos
5
Georgia
5
Iraq
4
Germany
4
Central African Republic
4
Hungary
4
Libya
4
Sri Lanka
4
Tajikistan
4
Morocco
3
Saudi Arabia
3
Egypt
3
Colombia
3
El Salvador
3
Bolivia
3
Mexico
3
Fiji
3
Bhutan
3
Palestine
3
Southern Africa
3
Timor Leste/ East Timor
3
Romania
3
Iran
3
Kyrgyzstan
3
Jamaica
3
Mauritius
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
USA
2
Gambia
2
Papua New Guinea
2
Argentina
2
Serbia
2
Ecuador
2
Chile
2
Armenia
2
Canada
2
Qatar
2
Bulgaria
2
Gabon
2
Japan
2
Tunisia
2
United Kingdom
2
Belarus
2
Niger
1
Turkey
1
Chad
1
Dominican Republic
1
Switzerland
1
Burundi
1
Honduras
1
Greece
1
Guatemala
1
Nicaragua
1
Other region
1
Djibouti
1
Mongolia
1
Lithuania
1
Slovakia
1
Kazakhstan
1
Turkmenistan
1
Denmark
1
Maldives
1
Norway
1
Portugal
1
Israel
1
Latvia
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
1416
Clinical Guidelines
295
Public Health
212
Women & Child Health
151
Key Resources
126
Capacity Building
39
Pharmacy & Technologies
38
Annual Report MEDBOX
1
Toolboxes
HIV
318
TB
246
AMR
210
COVID-19
194
Mental Health
179
Pharmacy
140
NCDs
88
Caregiver
87
Planetary Health
73
Disability
72
Malaria
71
NTDs
70
Conflict
66
Global Health Education
60
Ebola & Marburg
53
Health Financing Toolbox
50
Rapid Response
41
Refugee
40
Natural Hazards
20
2.0 Rapid Response
19
Polio
11
Zika
10
Specific Hazards
9
Cholera
5
Social Ethics
5
A Snapshot of European Collection Schemes
Research Article
Hindawi
BioMed Research International
Volume 2018, Article ID 9619684, 10 pages https://doi.org/10.1155/2018/9619684
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection
Accessed: 26.02.2020
Chronic kidney disease (CKD) is an important contributor to mortality from noncommunicable diseases. No decrease has been seen for CKD mortality contrary to many other important non-communicable diseases (e.g., cardiovascular disease). The prevalence of CKD and kidney failure are increasing all over
...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of
...
The checklist tool described in this handbook is intended for EU/EEA public health authorities who need to assess the capacity for communicable disease prevention and control at migrant reception/detention centres hosting migrants for weeks/months (medium-term) in order to identify gaps and set prio
...
Compendium of Case Studies
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six months treatment for children with minimal TB
Technical Brief
PLOS Glob Public Health 4(12): e0004035. https://doi. org/10.1371/journal.pgph.0004035.
A new formulation of praziquantel, arpraziquantel (arPZQ), has been developed for preschool-
aged children (PSAC) to fill the treatment gap for this age group in schistosomiasis control and
elimination program
...
Preliminary version for country introduction
This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, prsents current World Health Organization (WHO) guidance on the safety of various contraceptive e-
m
...